Ruxandra-ilinca Ibanescu

Montreal, QC H3T1E2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022.

Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022.

Journal: Viruses

Published: July 09, 2024

Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure.

Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure.

Journal: The Journal of antimicrobial chemotherapy

Published: February 02, 2023

The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002-2020).

The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002-2020).

Journal: Viruses

Published: July 19, 2021

Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada.

Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada.

Journal: Viruses

Published: March 03, 2021

Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir.

Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir.

Journal: The Journal of antimicrobial chemotherapy

Published: February 04, 2021

Assessing the role of transmission chains in the spread of HIV-1 among men who have sex with men in Quebec, Canada.

Assessing the role of transmission chains in the spread of HIV-1 among men who have sex with men in Quebec, Canada.

Journal: PloS one

Published: August 22, 2018

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.

Journal: Retrovirology

Published: July 05, 2018

Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.

Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.

Journal: Viruses

Published: December 07, 2017

Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1.

Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1.

Journal: Antimicrobial agents and chemotherapy

Published: August 15, 2017

M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA.

M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA.

Journal: The Journal of antimicrobial chemotherapy

Published: April 06, 2017

HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.

HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.

Journal: The Journal of antimicrobial chemotherapy

Published: January 19, 2017

Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec.

Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec.

Journal: AIDS (London, England)

Published: December 23, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026